Trastuzumab Emtansine

(asked on 5th September 2017) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what steps he is taking to make Kadcyla available to patients in the UK.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 13th September 2017

Trastuzumab emtansine (Kadcyla) has been funded and available to National Health Service patients in England since 2013 for the treatment of patients with HER2-positive unresectable, locally advanced or metastatic breast cancer after trastuzumab and a taxane.

Reticulating Splines